אבוסינאגיס 50 מ"ג

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

PALIVIZUMAB 50 MG

Disponible des:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

Codi ATC:

J06BB16

formulario farmacéutico:

POWDER FOR SOLUTION FOR INJECTION

Vía de administración:

I.M

Fabricat per:

ABBVIE S.R.L., ITALY

Grupo terapéutico:

PALIVIZUMAB

indicaciones terapéuticas:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Data d'autorització:

2010-07-01